MedPath

Single-center Ambispective Observational Study on the Role of Magnetic Resonance Imaging (MRI) in the Evaluation of Patient Affected by Hepatic Metastases of Carcinoma of the Colorectal Cancer (CRC).

Recruiting
Conditions
Colorectal Cancer
Interventions
Radiation: Hepatic MRI
Registration Number
NCT05950503
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

This study wants to evaluate the use of MRI in the managemente of mCRC with liver only metastases.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Age > 18 years;
  • Histological diagnosis of colorectal cancer;
  • Presence of liver metastases in the staging exams (chest-abdomen CT with contrast medium or PET-CT with 18-FDG);
  • At least one measurable liver lesion according to RECIST 1.1 criteria;
  • Adequate organ and marrow function.
Exclusion Criteria
  • Age < 18 years;
  • Inability to undergo MRI;
  • Major contraindications to liver surgery;
  • No written informed consent.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
mCRC patientsHepatic MRIPatients with mCRC with liver-only metastases
Primary Outcome Measures
NameTimeMethod
Surgery conversion rates3 years

Negative conversion rate is: patients initially considered operable and subsequently not considered suitable for surgery compared to the total number of patients enrolled.

Positive conversion rate is: patients initially deemed ineligible for surgery and subsequently operated, compared to the total number of patients enrolled.

Secondary Outcome Measures
NameTimeMethod
Overall survival3 years

Time from enrollment to death

Trial Locations

Locations (1)

Policlinico Agostino Gemelli

🇮🇹

Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath